New onset atrial fibrillation after transcatheter aortic valve implantation in Southwestern Colombia between 2009 and 2023

Background New-onset atrial fibrillation (NOAF) is an important complication after transcatheter aortic valve implantation (TAVI). Methods This retrospective cohort included 218 patients without documented pre-existing atrial fibrillation who underwent TAVI in Cali, Colombia, between 2009 and 2023. NOAF required an electrocardiographically documented episode lasting at least 30 s within 30 days. Clinical surveillance included inpatient telemetry and ECGs, scheduled follow-up and institutional readmissions; individual follow-up completeness was not quantified. We compared categorical characteristics and performed a sensitivity analysis restricted to recorded severe or critical aortic stenosis. Results NOAF was documented in 44/218 patients (20.2%; 95% CI, 15.4–26.0%). In the restricted subset, 35/164 had documented NOAF (21.3%; 95% CI, 15.8–28.2%). Chronic obstructive pulmonary disease was more frequent among patients with NOAF (61.4% versus 31.0%; unadjusted OR, 3.53; 95% CI, 1.78–7.01). Pacemaker implantation and low-molecular-weight heparin use were also more frequent in that group, describing perioperative co-occurrence. Conclusion Approximately one-fifth of patients had NOAF documented in the available records. Restriction to recorded severe or critical stenosis produced a similar frequency. The estimate describes clinical documentation within a 30-day window and requires interpretation in light of incomplete ascertainment and indication verification.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-16
DOI
https://doi.org/10.3389/fcvm.2026.1947079
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

New onset atrial fibrillation after transcatheter aortic valve implantation in Southwestern Colombia between 2009 and 2023

Mario Valladares Garrido, Jamil Cedillo-Balcázar, Antonio Dager, Jhony Alejandro Díaz-Vallejo et al.
Frontiers in Cardiovascular Medicine
Cardiac Valve Diseases and Treatments
article

New onset atrial fibrillation after transcatheter aortic valve implantation in Southwestern Colombia between 2009 and 2023

Mario Valladares Garrido, Jamil Cedillo-Balcázar, Antonio Dager, Jhony Alejandro Díaz-Vallejo, Jhon Quintana, Carlos Andrés Cardona, John Fernando Montenegro-Palacios, Nelson Murillo, yamil liscano, Diana Marcela Bonilla
article en

Abstract

Background New-onset atrial fibrillation (NOAF) is an important complication after transcatheter aortic valve implantation (TAVI). Methods This retrospective cohort included 218 patients without documented pre-existing atrial fibrillation who underwent TAVI in Cali, Colombia, between 2009 and 2023. NOAF required an electrocardiographically documented episode lasting at least 30 s within 30 days. Clinical surveillance included inpatient telemetry and ECGs, scheduled follow-up and institutional readmissions; individual follow-up completeness was not quantified. We compared categorical characteristics and performed a sensitivity analysis restricted to recorded severe or critical aortic stenosis. Results NOAF was documented in 44/218 patients (20.2%; 95% CI, 15.4–26.0%). In the restricted subset, 35/164 had documented NOAF (21.3%; 95% CI, 15.8–28.2%). Chronic obstructive pulmonary disease was more frequent among patients with NOAF (61.4% versus 31.0%; unadjusted OR, 3.53; 95% CI, 1.78–7.01). Pacemaker implantation and low-molecular-weight heparin use were also more frequent in that group, describing perioperative co-occurrence. Conclusion Approximately one-fifth of patients had NOAF documented in the available records. Restriction to recorded severe or critical stenosis produced a similar frequency. The estimate describes clinical documentation within a 30-day window and requires interpretation in light of incomplete ascertainment and indication verification.

Frontiers in Cardiovascular MedicineVol. 13
Universidad de Caldas (CO), Universidad Santiago de Cali (CO), Ministerio de Salud Pública (EC), Universidad Señor de Sipán (PE)
Good health and well-being
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon